← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2013Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (27 distinct, 20 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
Recent trials (24)
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT06924190OfficialN/ADec 30, 2024
- NCT06924190CollaboratorN/ADec 30, 2024
- NCT06216340OfficialPhase 4Feb 15, 2024
- NCT06216340CollaboratorPhase 4Feb 15, 2024
- NCT06240767Lead sponsorPhase 1Nov 1, 2023
- NCT05268172CollaboratorPhase 1Dec 20, 2022
- NCT05313529CollaboratorN/AOct 8, 2022
- NCT05305885CollaboratorN/AAug 19, 2022
- NCT05289908CollaboratorPhase 1/Phase 2Feb 21, 2022
- NCT05559450CollaboratorPhase 2Feb 1, 2022
- NCT05122572Lead sponsorPhase 1Nov 1, 2021
- NCT05136937Lead sponsorPhase 1Nov 1, 2021
- NCT04986436Overall official - principal investigatorPhase 1Jul 31, 2021
- NCT04911556Study directorN/AJun 1, 2021
Details
- Founded
- Wuxi, CN
- Last known activity
- Sep 1, 2025